Ledger.Open graph →
SEC Form D · filed July 1, 2020

Nine Square Therapeutics, Inc

Offering
$50.0M
Sold
$1.0M
Exemption
Rule 506(b)
Industry
Biotechnology
Location
NEW YORK, NY
Type
—

Rule 506(b): private placement to accredited investors, no public advertising.

People & firms on this filing (8)

Matthew Jacobson · Lewiston, MEDirectorSpiros Liras · New York, NYExec · DirectorSeth Harrison · Cambridge, MADirectorMichael Ehlers · New York, NYDirectorMatthew Jacobson · PORTLAND, ORDirectorSpiros Liras · New York, NYExec · DirectorSeth Harrison · New York, NYDirectorMichael Ehlers · New York, NYDirector

Public SEC Form D (Reg D) filing. · View issuer on SEC EDGAR ↗